http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Labcorp to Offer Risk-Scoring Test for People With Advanced Liver Fibrosis Due to NASH
-
Labcorp to Announce Fourth Quarter and Full Year 2021 Financial Results on February 10, 2022
-
Labcorp to Speak Virtually at the 40th Annual J.P. Morgan Healthcare Conference
-
Labcorp (LH) Acquires Personal Genome Diagnostics
-
Labcorp Strengthens Oncology Leadership Position With the Addition of Personal Genome Diagnostics, a Provider of Comprehensive Liquid Biopsy and Tissue-Based Genomic Products and Services
-
Labcorp (LH) Announces Initiatives to Enhance Shareholder Value
-
Labcorp Announces Initiatives to Enhance Shareholder Value
-
Labcorp Completes Acquisition of Toxikon Corporation
-
Labcorp and ConcertAI Optimize Precision Oncology Research With Real-World Data and Artificial Intelligence
-
Labcorp Now Offers Observed Collection for COVID-19 PCR Testing in Over 500 Locations Nationwide, With Plans to Expand to More Than 1,000 Locations
-
Laboratory Corporation (LH) to Acquire Toxikon
-
Labcorp to Acquire Toxikon, Expanding Nonclinical Development Testing Capabilities for Pharmaceutical, Biotech and Medical Device Clients
-
Labcorp and National Kidney Foundation Promote Patient Registry to Enhance Clinical Trial Accessibility, Diversity
-
Labcorp to Speak at Credit Suisse 30th Annual Healthcare Conference
-
Dr. Marcia Eisenberg, Labcorp Diagnostics Chief Scientific Officer, Named to Fierce Healthcare’s 2021 Women of Influence
-
Labcorp Announces 2021 Third Quarter Results
-
Lab Corp. (LH) Receives Emergency Use Authorization for At Home Collection Kit for Combined COVID-19 and Flu Detection
-
Labcorp Receives Emergency Use Authorization for At Home Collection Kit for Combined COVID-19 and Flu Detection
-
Labcorp to Announce Third Quarter Financial Results on October 28, 2021
-
Labcorp Completes Acquisition of Myriad Autoimmune’s Vectra Testing Business
-
Labcorp to Speak at Morgan Stanley 19th Annual Global Healthcare Conference
-
Lab Corp. (LH) Raises Minimum Wage to $15/h
-
Labcorp Raises Minimum Hourly Wage to $15 Per Hour
-
Labcorp and Community Clinical Oncology Research Network Collaborate to Assess Social and Economic Impacts of Disparities in Cancer Care
-
Lab Corp. (LH) Announces Acquisition of Ovia Health
-
Labcorp Extends Leadership in Women’s Health With Acquisition of Ovia Health
-
National Kidney Foundation and Labcorp Data Show Millions Aren't Tested for Kidney Disease
-
Labcorp Announces 2021 Second Quarter Results
-
Labcorp to Announce Second Quarter Financial Results on July 29, 2021
-
Lab Corp. (LH) Launches Companion Diagnostic for Amgen’s Newly-approved Lung Cancer Therapy
-
Labcorp Launches Companion Diagnostic for Amgen’s Newly-approved Lung Cancer Therapy
-
Labcorp And OmniSeq Launch INSIGHT℠, Next-Generation Sequencing Platform to Advance Precision Oncology
-
Lab Corp. (LH) Announces Pixel COVID-19 PCR Test Home Collection Kits Now Available Nationwide at Walgreens and Through On-Demand Delivery
-
Pixel by Labcorp® COVID-19 PCR Test Home Collection Kits Now Available Nationwide at Walgreens and Through On-Demand Delivery
-
Labcorp to Introduce Combined Oncology Offering at 2021 ASCO® Annual Meeting
-
Lab Corp. (LH) Study Suggests COVID-19 Antibodies Remain at Least 10 Months After Infection
-
Labcorp Study Suggests COVID-19 Antibodies Remain at Least 10 Months After Infection
-
Labcorp to Expand Bioanalytical Services With Integrated Laboratory in Singapore
-
Labcorp to Speak at UBS Global Healthcare Virtual Conference
-
Lab Corp. (LH) announces FDA granted EUA for its Pixel COVID-19 PCR Test Home Collection Kit for ages 2-17
-
Pixel by Labcorp COVID-19 PCR Test Home Collection Kit Receives FDA Emergency Authorization for Ages 2-17
-
Labcorp and the U.S. Department of Health and Human Services Join Forces to Raise Awareness of COVID-19 Treatments
-
Lab Corp. (LH) to Acquire Myriad Autoimmune’s Vectra Testing Business From Myriad Genetics
-
Labcorp to Acquire Myriad Autoimmune’s Vectra Testing Business From Myriad Genetics
-
GENFIT announces the launch by Labcorp of NASHnext® A Novel Noninvasive Diagnostic Test Powered by GENFIT’s NIS4™ Technology to Identify Patients with At-Risk NASH
-
Labcorp Announces 2021 First Quarter Results
-
Lab Corp. (LH) Launches COVID-19 Test Kits for Small Businesses
-
Labcorp Launches COVID-19 Test Kits for Small Businesses to Support Return to Work and Life Safely
-
Labcorp to Webcast Its Annual Meeting of Shareholders
-
Labcorp to Announce First Quarter Financial Results on April 29, 2021

